Navigation Links
ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012
Date:2/28/2012

SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release its unaudited financial results for the fourth quarter and full year ended December 31, 2011 on March 13, 2012. Management will host a conference call to discuss the results at 08:00AM New York Time on March 13, 2012 (08:00PM Beijing Time on March 13, 2012).

Conference Call

Mr. Michael Xin Hui, founder and Chief Executive Officer; Mr. William Dai, Chief Financial Officer; and Ms. Lan Xie, Vice President of Finance and Investor Relations, will discuss the results and take questions following the prepared remarks.

Dial-in details for the live conference call are as follows:

International: +1-718-354-1231
United States: +1-866-519-4004
United Kingdom: 080-8234-6646
Hong Kong: +852-2475-0994

Passcode: SHP

A live webcast of the conference call will be available on the investor relations section of the Company's website at: http://www.shangpharma.com.

A telephone replay of the call will be available for seven days from March 13, 2012, 11:00AM U.S. Eastern Time to March 20, 2012, 11:59PM U.S. Eastern Time. The dial-in details for the replay are as follows:

International: +61-2-8235-5000
Passcode: 57079920

ABOUT SHANGPHARMA CORPORATION

ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

For further information, please contact: 

ShangPharma
Ms. Lan Xie
Vice President of Finance and Investor Relations
Email: ir@shangpharma.com

Brunswick Group
Josh Gartner
Email: shangpharma@brunswickgroup.com
Phone: 86-10-5960-8600

 


'/>"/>
SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma to Present at Cowens 32nd Annual Health Care Conference
2. ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
3. ShangPharma Announces Opening of New Facility to Support Lillys Pipeline
4. ShangPharma to Attend Two Upcoming Investor Conferences
5. ShangPharma Announces Third Quarter 2011 Results
6. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
7. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
8. ShangPharma Corporation Announces Resignation of a Director
9. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
10. ShangPharma Announces Up to $10 Million Share Repurchase Program
11. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... BERLIN , April 29, 2016 ... world-leading glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years ... pharmaceutical and biotechnology industries. His last role was at ... Member of the Executive Board. Previously Dr. Zurlo held ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... Eating Recovery Center’s Insight Behavioral Health ... anxiety disorders, has rebranded its eating disorder program under a new name: Eating Recovery ... facility on May 16. , To celebrate, ERC Chicago will host a ribbon-cutting ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... Data Book for the 2016 Main Residency Match® (“the Match”), the system through ... United States teaching institutions. A record-high 30,750 positions were placed in the 2016 ...
(Date:5/2/2016)... ... May 02, 2016 , ... East Los Angeles dentist , ... can visit Dr. Assili to receive any dental extraction treatment for $40 off the ... June 30, 2016. With the lower price, patients can more easily afford extractions to ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their ... from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results ...
(Date:5/2/2016)... PORT RICHEY, Fla. (PRWEB) , ... ... ... experts and medical researchers report that many commonly used prescription medications, including ... loss (1). To mitigate these risks, Novus Medical Detox Center —a ...
Breaking Medicine News(10 mins):